Close Menu

Investing in Biotech

Randal Kirk, one of the only billionaires to make his money from investing in biotech, says his new synthetic biology company, Intrexon, will be the biggest thing he has ever done, says Forbes' Robert Langreth and Matthew Herper. The company is working on protein-based drugs, gene therapy, industrial enzymes, and ag-bio.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

In a letter, about two dozen researchers criticize the World Health Organization investigation into the origins of SARS-CoV-2 and call for a new inquiry, the Wall Street Journal reports.

National Geographic reports that nine great apes at the San Diego Zoo have been vaccinated against SARS-CoV-2.

Janet Woodcock, the acting commissioner of the US Food and Drug Administration, speaks with NPR about SARS-CoV-2 testing and vaccines in the US.

In Science this week: genetic study of kidney fibrosis implicates the SOX9-NAV3-YAP1 axis.